Form 4 for DRIO DarioHealth Corp.
Accepted 2022-05-20 00:00:00 ET · period of report 2022-05-18 · accession 0001104659-22-063457 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-20 | 2022-05-18 | DRIO | Ben-David Zvi | CFO | A - Grant | $0.00 | +95.0K | 346.0K | +38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-18 | A | A | 95,000 | $0.00 | 346,035 | D | — | — | (F1) The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter. |